PANAKEIA TO BE DISTRIBUTED IN THE U.S.A. BY TWO LOCAL COMPANIES
HEMP TRADING ENTERS THE AMERICAN MARKET WITH THE FIRST THC-FREE AND HIGH CBG HEMP VARIETY
(Spain, December 18, 2019). Panakeia, the first THC-free (0.00%) hemp variety with high CBG content (18%) lands in the U.S.A. Developed by Hemp Trading, Panakeia seeds and clones will be produced and distributed by Tesoro Genetics, specialising in breeding high quality hemp seed and CBD, and Front Range Biosciences, a technology provider for the breeding and production of new hemp, coffee and regulated cannabis plant varieties and seeds.
Hemp Trading developed this strain together with the Spanish university Universidad Politècnica de Valencia and signed the commercial agreements with these two large companies at MJBizCon, the biggest trade show of the cannabis industry, which was hold in Las Vegas last week. This agreement will enable large-scale production and distribution of Panakeia in the American market.
SPANISH COMPANY HEMP TRADING DEVELOPS THE FIRST THC FREE STRAIN AND WITH HIGH MEDICINAL POTENTIAL
The new strain, the only one in the cannabis market, is totally legal as it is free of psychoactive components and stands out for its big therapeutic potential in the treatment of illnesses such as Crohn’s disease, colon cancer, glaucoma, Parkinson’s and Alzheimer’s, among others.
(Spain, October 2019). The Spanish Company Hemp Trading, specialised in the international distribution of products for cannabis growth, has developed, together with the Spanish University Universitat Politècnica de Valencia (UPV), the first cannabis strain THC free with high medicinal potential. It’s a very attractive strain specially for medicinal cannabis patients for its therapeutic properties to treat illnesses such as Crohn’s, colon cancer, glaucoma, Parkinson’s and Alzheimer’s, among others.